Abnormal epidermal barrier in the pathogenesis of contact dermatitis

Clinics in Dermatology

Volumn 30, Issue 3, 2012, Pages 335-344

  Proksch, Ehrhardt ^a   Brasch, Jochen ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALLERGEN; BETAMETHASONE; CALCINEURIN INHIBITOR; CERAMIDE; CORTICOSTEROID; CYCLOSPORIN; CYTOKINE; DESMOSOMAL PROTEIN; ETRETIN; FILAGGRIN; PIMECROLIMUS; PROTEIN; RETINOID; SKIN LIPID; TACROLIMUS; UNCLASSIFIED DRUG;

ABNORMAL EPIDERMAL BARRIER; ATOPIC DERMATITIS; CELL DAMAGE; CONTACT DERMATITIS; CREAM; DERMATITIS; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; EPIDERMIS; EPIDERMIS BARRIER; GENE MUTATION; GENETIC POLYMORPHISM; HAND DISEASE; HOMEOSTASIS; HUMAN; HYPERKERATOSIS; ICHTHYOSIS; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KERATINOCYTE; LANGERHANS CELL; LONG TERM CARE; NONHUMAN; NOTE; OXIDATION REDUCTION REACTION; PATCH TEST; PERMEABILITY BARRIER; PHOTOTHERAPY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; PROTEIN MODIFICATION; PSORIASIS; SIGNAL TRANSDUCTION; SKIN DISEASE; SKIN FUNCTION; SKIN INFLAMMATION; SKIN PENETRATION; SKIN PROTECTION; SKIN SURFACE; STRATUM CORNEUM; T LYMPHOCYTE; TIGHT JUNCTION; TISSUE DIFFERENTIATION; TISSUE GROWTH; TISSUE REPAIR;

ADMINISTRATION, TOPICAL; ALLERGENS; DERMATITIS, CONTACT; EPIDERMIS; HUMANS; IRRITANTS; PERMEABILITY; SKIN ABSORPTION; TIME FACTORS;

EID: 84859754247     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2011.08.019     Document Type: Note

References (104)

1. Del Rosso J. Protecting the hand-skin barrier in the workplace. Occup Health Saf 2001, 70:116-120.
2. Antezana M., Parker F. Occupational contact dermatitis. Immunol Allergy Clin North Am 2003, 23:269-290.
3. Nielsen J.B., Nielsen F., Sørensen J.A. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin. Arch Dermatol Res 2007, 299:423-431.
4. Slodownik D., Nixon R. Occupational factors in skin diseases. Curr Probl Dermatol 2007, 35:173-189.
5. Fluhr J.W., Darlenski R., Angelova-Fischer I., et al. Skin irritation and sensitization: mechanisms and new approaches for risk assessment. 1. Skin irritation. Skin Pharmacol Physiol 2008, 21:124-135.
6. Pickard C., Louafi F., McGuire C., et al. The cutaneous biochemical redox barrier: a component of the innate immune defenses against sensitization by highly reactive environmental xenobiotics. J Immunol 2009, 183:7576-7584.
7. Rustemeyer T., Hoogstraten I.M.W., Blomberg B.M.E., Gibbs S., Scheper R.J. Mechanisms of irritant and allergic contact dermatitis. Contact dermatitis 2011, 43-75. Springer, Berlin. 5th ed. J.D. Johansen, P.J. Frosch, J.P. Lepoittevin (Eds.).
8. Madison K.C. Barrier function of the skin: ' la raison d'etre' of the epidermis. J Invest Dermatol 2003, 121:231-241.
9. Roop D. Defects in the barrier. Science 1995, 267:474.
10. Candi E., Schmidt R., Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005, 6:328-340.
11. Ahrens K., Schunck M., Podda G.F., et al. Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14. J Invest Dermatol 2011, 131:443-452.
12. Gläser R., Meyer-Hoffert U., Harder J., et al. The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption. J Invest Dermatol 2009, 129:641-649.
13. Harder J., Dressel S., Wittersheim M., et al. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010, 130:1355-1364.
14. Meyer-Hoffert U., Knoop J., Dressel S., et al. Differential regulation of antimicrobial peptides in contact dermatitis R. J Invest Dermatol 2010, 130:S5.
15. Cavani A. Immune regulatory mechanisms in allergic contact dermatitis and contact sensitization. Chem Immunol Allergy 2008, 94:93-100.
16. Vocanson M., Hennino A., Rozières A., et al. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 2009, 64:1699-1714.
17. Albanesi C. Keratinocytes in allergic skin diseases. Curr Opin Allergy Clin Immunol 2010, 10:452-456.
18. Gober M.D., Gaspari A.A. Allergic contact dermatitis. Curr Dir Autoimmun 2008, 10:1-26.
19. Fonacier L.S., Dreskin S.C., Leung D.Y.M. Allergic skin diseases. J Allergy Clin Immunol 2010, 125:S138-S149.
20. Bouwstra J.A., Pilgrim K., Ponec M. Structure of the skin barrier. Skin barrier 2006, 65. Taylor and Francis, New York. P.M. Elias, K.R. Feingold (Eds.).
21. Nemes Z., Steinert P.M. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999, 31:5-19.
22. Webb A., Li A., Kaur P. Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation 2004, 72:387-395.
23. Jensen J.M., Schütze S., Neumann C., et al. Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice. J Invest Dermatol 2000, 115:708-713.
24. Swartzendruber D.C., Wertz P.W., Madison K.C., et al. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 1987, 88:709.
25. Matsuki M., Yamashita F., Ishida-Yamamoto A. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A 1998, 95:1044-1049.
26. Huber M., Rettler I., Bernasconi K., et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 1995, 267:525-528.
27. Brandner J.M., Proksch E. Epidermal barrier function: role of tight junctions. Skin barrier 2006, 191. Taylor and Francis, New York. P.M. Elias, K.R. Feingold (Eds.).
28. Proksch E., Brandner J.M., Jensen J.M. The skin: an indispensable barrier. Exp Dermatol 2008, 17:1063-1072.
29. Jensen J.M., Fölster-Holst R., Baranowsky A., et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004, 122:1423-1431.
30. Proksch E., Elias P.M., Feingold K.R. Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest 1990, 85:874.
31. Ishida-Yamamoto A., Iizuka H. Structural organization of cornified cell envelopes and alterations in inherited skin disorders. Exp Dermatol 1998, 7:1-10.
32. Jensen J.M., Proksch E., Elias P.M. The stratum corneum of the epidermis in atopic dermatitis. Skin barrier 2006, 569. Taylor and Francis, New York. P.M. Elias, K.R. Feingold (Eds.).
33. Bonneville M., Chavagnac C., Vocanson M., et al. Skin contact irritation conditions the development and severity of allergic contact dermatitis. J Invest Dermatol 2007, 127:1430-1435.
34. Dickel H., Gambichler T., Kamphowe J., et al. Standardized tape stripping prior to patch testing induces upregulation of Hsp90, Hsp70, IL-33, TNF-α and IL-8/CXCL8 mRNA: new insights into the involvement of 'alarmins. Contact Dermatitis 2010, 63:215-222.
35. Schürer N.Y., Klippel U., Schwanitz H.J. Secondary individual prevention of hand dermatitis in geriatric nurses. Int Arch Occup Environ Health 2005, 78:149-157.
36. Kütting B., Drexler H. Effectiveness of skin protection creams as a preventive measure in occupational dermatitis: a critical update according to criteria of evidence-based medicine. Int Arch Occup Environ Health 2003, 76:253-259.
37. Hachem J.P., De Paepe K., Sterckx G., et al. Evaluation of biophysical and clinical parameters of skin barrier function among hospital workers. Contact Dermatitis 2002, 46:220-223.
38. Williams C., Wilkinson S.M., McShane P., et al. A double-blind, randomized study to assess the effectiveness of different moisturizers in preventing dermatitis induced by hand washing to simulate healthcare use. Br J Dermatol 2010, 162:1088-1092.
39. Brasch J., Schnuch A., Uter W. Strong allergic patch test reactions may indicate a general disposition for contact allergy. Allergy 2006, 61:364-369. German Contact Dermatitis Research Group (DKG) and the Information Network of Departments of Dermatology (IVDK).
40. Brasch J., Geier J., Henseler T. Evaluation of patch test results by use of the reaction index. An analysis of data recorded by the Information Network of Departments of Dermatology (IVDK). Contact Dermatitis 1995, 33:375-380.
41. Kambe N., Nakamura Y., Saito M., et al. The inflammasome, an innate immunity guardian, participates in skin urticarial reactions and contact hypersensitivity. Allergology Int 2010, 59:105-113.
42. Arthur J.C., Lich J.D., Ye Z., et al. NLRP12 controls dendritic and myeloid cell migration to affect contact hypersensitivity. J Immunol 2010, 185:4514-4519.
43. Schnuch A., Brasch J., Lessmann H., et al. A further characteristic of susceptibility to contact allergy: sensitization to a weak contact allergen is associated with polysensitization. Results of the IVDK. Contact Dermatitis 2007, 56:331-337.
44. Schnuch A., Brasch J., Uter W. Polysensitization and increased susceptibility in contact allergy: a review. Allergy 2008, 63:156-167.
45. Schaefer H., Redlmeier T.E., Lademann J. Skin penetration. Contact dermatitis 2011, 215-225. Springer, Berlin. 5th ed. J.D. Johansen, P.J. Frosch, J.P. Lepoittevin (Eds.).
46. Vestergaard L., Clemmensen O.J., Sørensen F.B., et al. Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis. Contact Dermatitis 1999, 41:207-210.
47. Dotterud L.K., Smith-Sivertsen T. Allergic contact sensitization in the general adult population: a population-based study from Northern Norway. Contact Dermatitis 2007, 56:10-15.
48. McFadden J. Contact allergic reactions in patients with atopic eczema. Acta Derm Venereol Suppl (Stockh) 2005, 215:28-32.
49. Buchvald D. Contact dermatitis and atopic dermatitis-rare comorbidity?. Cas Lek Cesk 2010, 149:217-220.
50. Brasch J., Schnuch A., Uter W. Patch-test reaction patterns in patients with a predisposition to atopic dermatitis. Contact Dermatitis 2003, 49:197-201.
51. Proksch E., Foelster-Holst R., Jensen J.M. Skin barrier function, epidermal proliferation and differentiation in eczema. J Dermatol Science 2006, 43:159-169.
52. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
53. Ruether A., Stoll M., Schwarz T., et al. Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany. Br J Dermatol 2006, 155:1093-1094.
54. Weidinger S., Illig T., Baurecht H., et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol 2006, 118:214-219.
55. Brown S.J., Cordell H.J. Are filaggrin mutations associated with hand eczema or contact allergy? We do not know. Br J Dermatol 2008, 158:1383-1384.
56. Lerbaek A., Bisgaard H., Agner T., et al. Filaggrin null alleles are not associated with hand eczema or contact allergy. Br J Dermatol 2007, 157:1199-1204.
57. Giwercman C., Lerbaek A., Bisgaard H., et al. Classification of atopic hand eczema and the filaggrin mutations. Contact Dermatitis 2008, 59:257-260.
58. Molin S., Vollmer S., Weiss E.H., et al. Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis. Br J Dermatol 2009, 161:801-807.
59. Novak N., Baurecht H., Schäfer T., et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol 2008, 128:1430-1435.
60. van den Oord R.A., Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ 2009, 339:b2433.
61. Proksch E., Jensen J.M., Elias P.M. Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 2003, 21:134.
62. Macheleidt O., Kaiser H.W., Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002, 19:166-173.
63. Fartasch M., Bassukas I.D., Diepgen T.L. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992, 127:221-227.
64. di Nardo A., Sugino K., Wertz P., et al. Sodium lauryl sulfate(SLS) induced irritant contact dermatitis: a correlation study between ceramides and in vivo parameters of irritation. Contact Dermatitis 1996, 35:86-91.
65. Heinemann C., Paschold C., Fluhr J., et al. Induction of a hardening phenomenon by repeated application of SLS: analysis of lipid changes in the stratum corneum. Acta Derm Venereol 2005, 85:290-295.
66. Friebe K., Effendy I., Löffler H. Effects of skin occlusion in patch testing with sodium lauryl sulphate. Br J Dermatol 2003, 148:65-69.
67. Warner R.R., Stone K.J., Boissy Y.L. Hydration disrupts human stratum corneum ultrastructure. J Invest Dermatol 2003, 120:275-284.
68. Brasch J. Current knowledge of host response in human tinea. Mycoses 2009, 52:304-312.
69. Jensen J.M., Pfeiffer S., Akaki T., et al. Barrier function, epidermal differentiation, and human beta-defensin 2 expression in tinea corporis. J Invest Dermatol 2007, 127:1720-1727.
70. Rosén K., Jontell M., Mobacken H., et al. Epidermal Langerhans' cells in chronic eczematous dermatitis of the palms treated with PUVA and UVB. Acta Derm Venereol 1989, 69:200-205.
71. Sterry W., Künne N., Weber-Matthiesen K., et al. Cell trafficking in positive and negative patch-test reactions: demonstration of a stereotypic migration pathway. J Invest Dermatol 1991, 96:459-462.
72. Kondo H., Ichikawa Y., Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998, 28:769-779.
73. Proksch E., Brasch J., Sterry W. Integrity of the permeability barrier regulates epidermal Langerhans cell density. Br J Dermatol 1996, 134:630-638.
74. Proksch E., Brasch J. Influence of epidermal permeability barrier disruption and Langerhans' cell density on allergic contact dermatitis. Acta Derm Venereol 1997, 77:102-104.
75. Nishijima T., Tokura Y., Imokawa G., et al. Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption. J Invest Dermatol 1997, 109:175-182.
76. Spier H.W., Sixt I. Untersuchungen über die Abhängigkeit des Ausfalles der Ekzem-Läppchenprobe von der Hornschichtdicke. Quantiativer Abriβ-Epikutantest. Hautarzt 1955, 6:152-159.
77. Jung E.G. Nachweis der beginnenden Bichromat-Sensibilisierung von Zementekzematikern mittels des Abrisstests. Berufsdermatosen 1963, 11:93-103.
78. Kühl M., Klaschka F. Berufsdermatosen 1990, 204. Urban & Schwarzenberg, München.
79. Dickel H., Bruckner T.M., Erdmann S.M., et al. The strip patch test: results of a multicentre study towards a standardization. Arch Dermatol Res 2004, 296:212-219.
80. Dickel H., Geier J., Kuss O., et al. Strip patch test vs. conventional patch test to detect type IV sensitization in patients with allergic contact dermatitis. J Eur Acad Dermatol Venereol 2008, 22:1516-1517.
81. Dickel H., Kamphowe J., Geier J., et al. Strip patch test vs. conventional patch test: investigation of dose-dependent test sensitivities in nickel- and chromium-sensitive subjects. J Eur Acad Dermatol Venereol 2009, 23:1018-1025.
82. Fernandez M.F.M., de Mello J.F., Pires M.C., et al. Comparative study of patch test using traditional method vs. prior skin abrading. J Eur Acad Dermatol Venereol 2007, 21:1351-1359.
83. Gebhard K.L., Effendy I., Löffler H.L. Artificial disruption of skin barrier prior to irritant patch testing does not improve test design. Br J Dermatol 2004, 150:82-89.
84. Schurer N.Y. Implementation of fatty acid carriers to skin irritation and the epidermal barrier. Contact Dermatitis 2002, 47:199-205.
85. Endo K., Suzuki N., Yoshida O., et al. The barrier component and the driving force component of transepidermal water loss and their application to skin irritant tests. Skin Res Technol 2007, 13:425-435.
86. Jensen J.M., Pfeiffer S., Witt M., et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2009, 123:1124-1133.
87. Ghadially R., Halkier-Sörensen L., Elias P.M. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 1992, 26:387-396.
88. Loden M., Andersson A.C., Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999, 140:264-267.
89. Tabata N., O'Goshi K., Zhen Y.X., et al. Biophysical assessment of persistent effects of moisturizers after their daily applications: evaluation of corneotherapy. Dermatology 2000, 200:308.
90. Proksch E., Feingold K.R., Man M.Q., et al. Barrier function regulates epidermal DNA synthesis. J Clin Invest 1991, 87:1668-1673.
91. Chamlin S.L., Frieden I.J., Fowler A., et al. Ceramide-dominant, barrier repair lipids improve childhood atopic dermatitis. Arch Dermatol 2001, 137:1110-1112.
92. Berardesca E., Barbareschi M., Veraldi S., et al. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis 2001, 45:280-285.
93. Tappeiner G. Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial. Int Arch Occup Environ Health 2009, 82:653-662.
94. Kütting B., Uter W., Baumeister T., et al. Non-invasive bioengineering methods in an intervention study in 1020 male metal workers: results and implications for occupational dermatology. Contact Dermatitis 2010, 62:272-278.
95. Zhai H., Maibach H.I. Protection from irritants. Curr Probl Dermatol 2007, 34:47-57.
96. Saary J., Qureshi R., Palda V., et al. A systematic review of contact dermatitis treatment and prevention. J Am Acad Dermatol 2005, 53:845.
97. Alvarez M.S., Brown L.H., Brancaccio R.R. Are barrier creams actually effective?. Curr Allergy Asthma Rep 2001, 1:337-341.
98. Winker R., Salameh B., Stolkovich S., et al. Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial. Int Arch Occup Environ Health 2009, 82:653-662.
99. Korinth G., Lüersen L., Schaller K.H., et al. Enhancement of percutaneous penetration of aniline and o-toluidine in vitro using skin barrier creams. Toxicol In Vitro 2008, 22:812-818.
100. Wetzky U., Bock M., Wulfhorst B., et al. Short- and long-term effects of single and repetitive glove occlusion on the epidermal barrier. Arch Dermatol 2009, 301:595-602.
101. Garnock-Jones K.P., Perry C.M. Alitretinoin: in severe chronic hand eczema. Drugs 2009, 69:1625-1634.
102. Elias P.M., Fritsch P.O., Lampe M., et al. Retinoid effects on epidermal structure, differentiation, and permeability. Lab Invest 1981, 44:531-540.
103. Wilhelm K.P., Freitag G., Wolff H.H. Surfactant-induced skin irritation and skin repair: evaluation of a cumulative human irritation model by noninvasive techniques. J Am Acad Dermatol 1994, 31:981-987.
104. Lee J.Y., Effendy I., Maibach H.I. Acute irritant contact dermatitis: recovery time in man. Contact Dermatitis 1997, 36:285-290.